← Back to patent-cliff list
Phenylephrine Hydrochloride/Tropicamide
Tier C — Watch / tradePhenylephrine Hydrochloride/Tropicamide
Eyenovia Inc
Originator
1996
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：mAChRs, ADRA1
Brand：MydCombi
Indications (approved)：Mydriasis
Regional status
US
Withdrawn
EU
Phase II
2025-11-01
China
Approved
1996-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Phenylephrine Hydrochloride/Tropicamide?
Approved indications include: Mydriasis.
When does the Phenylephrine Hydrochloride/Tropicamide patent expire?
No public expiry year is available for Phenylephrine Hydrochloride/Tropicamide yet; this page updates once verified.
How do I get a quote for Phenylephrine Hydrochloride/Tropicamide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04